Treating Cardiovascular Disease with Liver Genome Engineering.

"Declarations Conflict of InterestDr. Lagor reports non-financial support from Alnylam Pharmaceuticals, outside the submitted work. In addition, Dr. Lagor and Mrs. Hurley have a patent application pending “Selective expansion of gene-targeted cells” [WO2021108269A1]. Human and Animal RightsAll reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines). Conflict of Interest Dr. Lagor reports non-financial support from Alnylam Pharmaceuticals, outside the submitted work. In addition, Dr. Lagor and Mrs. Hurley have a patent application pending “Selective expansion of gene-targeted cells” [WO2021108269A1]."

"This work was supported by funding from the National Institutes of Health to W.R.L. (HL151545, HL132840, DK124477, OD026645)."